ARTICLE | Company News

Management tracks: Immunomedics, WuXi

November 10, 2017 10:14 PM UTC

Antibody company Immunomedics Inc. (NASDAQ:IMMU) appointed Michael Pehl president and CEO, effective Dec. 7, and Brendan Delaney chief commercial officer. Interim CEO Michael Garone will resume his role as CFO. Pehl was president of hematology & oncology, and Delaney was VP of U.S. commercial hematology oncology, both at Celgene Corp. (NASDAQ:CELG).

Contract genomics services company WuXi NextCode Genomics Inc. (Cambridge, Mass.) hired John Gu as chief digital officer. He was managing director at Silver Sand Technologies LLC (Muscat, Oman) and former chief information officer at Baidu Inc. (NASDAQ:BIDU)...